ABOUT THE EXPERT

Brian D. Moseley,

MD

Assistant Professor
Department of Neurology and Rehabilitation Medicine
University of Cincinnati
Cincinnati, OH

Brian D. Moseley, MD, is an assistant professor in the Department of Neurology and Rehabilitation Medicine at the University of Cincinnati in Cincinnati, OH. He was previously a clinical instructor at the University of California, Los Angeles, and an assistant professor of neurology at the Mayo Clinic in Rochester, MN.  

Dr Moseley earned his medical degree from Loma Linda University School of Medicine in Loma Linda, CA. He completed an internal medicine internship and an adult neurology residency at the Mayo School of Graduate Medical Education in Rochester, MN. He continued his training at the University of California, Los Angeles, with a 2-year clinical neurophysiology/epilepsy fellowship.

Dr Moseley’s primary research interest is studying the autonomic effects of seizures and how they may relate to sudden unexpected death in epilepsy. He was the first to publish on cerebral oximetric changes during seizures using noninvasive transcutaneous near-infrared spectroscopy and how such changes relate to risk factors for sudden unexpected death in epilepsy. He has authored or co-authored 2 book chapters, 12 editorials and reviews, and more than 40 peer-reviewed journal articles. He has served as a reviewer for more than 25 medical journals, including Neurology; Journal of Neurology, Neurosurgery, and Psychiatry; Epilepsy & Behavior; Epilepsy Research; and Epilepsia. Dr Moseley is a member of the American Academy of Neurology and is a fellow of the American Epilepsy Society. He is a recipient of various awards and honors, including the Mayo Clinic Department of Neurology Research Award in 2012. He is a national and international lecturer and speaker.

CONTRIBUTING ARTICLES

Neurology / Epilepsy

The Genetics of Epilepsy in Clinical Practice

expert roundtables by Selim R. Benbadis, MD; Brian D. Moseley, MD; and James W. Wheless, BSPharm, MD, FAAP, FACP, FAAN, FAES

While precision therapy is not possible for most patients with epilepsy, genetic testing in specific scenarios helps to inform the patient’s progno...READ MORE